Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models
published in: Neuro-Oncology
date of publication: 2016-03-09
main subject: bevacizumab, glioblastoma, neoplastic invasiveness
Cites articles 44
Date
Title
Article - wd:Q39930556